CN110862463A - Preparation of alfalfa root polysaccharide with bioactivity and selenizing modified polysaccharide thereof - Google Patents
Preparation of alfalfa root polysaccharide with bioactivity and selenizing modified polysaccharide thereof Download PDFInfo
- Publication number
- CN110862463A CN110862463A CN201910971326.1A CN201910971326A CN110862463A CN 110862463 A CN110862463 A CN 110862463A CN 201910971326 A CN201910971326 A CN 201910971326A CN 110862463 A CN110862463 A CN 110862463A
- Authority
- CN
- China
- Prior art keywords
- polysaccharide
- raps
- daps
- alfalfa
- alfalfa root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 85
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 85
- 150000004676 glycans Chemical class 0.000 title claims abstract description 81
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 title claims abstract description 45
- 241000219823 Medicago Species 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 16
- 230000000694 effects Effects 0.000 claims abstract description 13
- 101000735888 Dictyostelium discoideum Proteasome subunit beta type-6 Proteins 0.000 claims abstract description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 10
- 239000011780 sodium chloride Substances 0.000 claims abstract description 5
- 238000005349 anion exchange Methods 0.000 claims abstract description 3
- 230000004071 biological effect Effects 0.000 claims abstract description 3
- 238000004440 column chromatography Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 229910052711 selenium Inorganic materials 0.000 claims description 8
- 239000011669 selenium Substances 0.000 claims description 8
- 229940091258 selenium supplement Drugs 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 239000003208 petroleum Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- -1 selenium polysaccharide Chemical class 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 3
- 240000002791 Brassica napus Species 0.000 claims description 2
- TUTXBWOKAJDVSC-UHFFFAOYSA-L [Na+].[Na+].O[N+]([O-])=O.[O-][Se]([O-])=O Chemical compound [Na+].[Na+].O[N+]([O-])=O.[O-][Se]([O-])=O TUTXBWOKAJDVSC-UHFFFAOYSA-L 0.000 claims description 2
- 230000035614 depigmentation Effects 0.000 claims description 2
- 230000003544 deproteinization Effects 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 150000003384 small molecules Chemical class 0.000 claims description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract description 10
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 abstract description 10
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract description 10
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract description 7
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 6
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract description 4
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 abstract description 4
- 239000008103 glucose Substances 0.000 abstract description 4
- 238000004458 analytical method Methods 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 3
- 229930182830 galactose Natural products 0.000 abstract description 3
- 238000012986 modification Methods 0.000 abstract description 3
- 230000004048 modification Effects 0.000 abstract description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 2
- 230000001419 dependent effect Effects 0.000 abstract description 2
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 239000008367 deionised water Substances 0.000 abstract 1
- 229910021641 deionized water Inorganic materials 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 5
- 240000004658 Medicago sativa Species 0.000 description 5
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229940097043 glucuronic acid Drugs 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 4
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 229960001471 sodium selenite Drugs 0.000 description 3
- 239000011781 sodium selenite Substances 0.000 description 3
- 235000015921 sodium selenite Nutrition 0.000 description 3
- 108090000145 Bacillolysin Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 102000035092 Neutral proteases Human genes 0.000 description 2
- 108091005507 Neutral proteases Proteins 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000010624 Medicago sativa Nutrition 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000005918 in vitro anti-tumor Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000006883 memory enhancing effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000012184 tortilla Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Sustainable Development (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种天然药物改性多糖的制备,特别是涉及一种具有生物活性的紫花苜蓿根部多糖及其硒化改性多糖的制备。The invention relates to the preparation of a natural medicine modified polysaccharide, in particular to the preparation of a biologically active alfalfa root polysaccharide and its selenization modified polysaccharide.
背景技术Background technique
紫花苜蓿(Medicago sativa L.)是一种多年生的豆科牧草作物,广泛栽培于世界各地的温带地区。紫花苜蓿对于牧民来说是一种很重要的工业作物。此外,紫花苜蓿还可以也作为一种蔬菜被食用,世界各地的人们将其制成了沙拉,玉米饼,炸肉饼,布丁,汤和砂锅菜。作为一种功能性食品,紫花苜蓿在中国古代的许多药用书籍中被记载,比如《药物纲要》,并被古人当做所有食物之父。紫花苜蓿被用作牧草和蔬菜时,由于其含有丰富的营养价值,因此发挥出了潜在的健康促进作用,包括抗氧化性,抗炎,抗癌,抗菌,免疫增强和提高记忆力作用。大量的对紫花苜蓿活性成分的研究分离出了许多化学成分。因为紫花苜蓿含有优质的营养成分和各种不同的生物活性。Alfalfa ( Medicago sativa L.) is a perennial legume forage crop widely cultivated in temperate regions around the world. Alfalfa is an important industrial crop for herders. In addition, alfalfa is also eaten as a vegetable, and people around the world make it into salads, tortillas, croquettes, puddings, soups and casseroles. As a functional food, alfalfa has been recorded in many medicinal books in ancient China, such as the "Compendium of Medicine", and was regarded as the father of all foods by the ancients. When alfalfa is used as a pasture and vegetable, it exhibits potential health-promoting effects due to its rich nutritional value, including antioxidant, anti-inflammatory, anti-cancer, antibacterial, immune-enhancing, and memory-enhancing effects. Numerous studies of active ingredients in alfalfa have isolated many chemical constituents. Because alfalfa contains high-quality nutrients and a variety of different biological activities.
紫花苜蓿多糖(alfalfa polysaccharide)是从紫花苜蓿植株中提取出来的植物多糖。到目前为止,在紫花苜蓿的体外实验中,其具有免疫增强活性,抗肿瘤,降血糖和抗氧化活性。此外,紫花苜蓿多糖还被发现具有促进家畜和家禽生长的作用。由于紫花苜蓿多糖具有特殊的生物学功能和丰富的来源,因此,紫花苜蓿多糖具有巨大的应用潜力。Alfalfa polysaccharide is a plant polysaccharide extracted from alfalfa plants. So far, in the in vitro experiments of alfalfa, it has immune-enhancing activity, anti-tumor, hypoglycemic and antioxidant activity. In addition, alfalfa polysaccharides have also been found to promote the growth of livestock and poultry. Because alfalfa polysaccharides have special biological functions and rich sources, alfalfa polysaccharides have great application potential.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种具有生物活性的紫花苜蓿根部多糖及其硒化改性多糖的制备,本发明制备的多糖化和硒化多糖具有一定的抗HepG-2肿瘤活性。为多糖的结构修饰,多糖的活性分析以及抗肿瘤方面疾病有关的功能性保健品和药物的开发奠定了理论基础。The purpose of the present invention is to provide a biologically active alfalfa root polysaccharide and the preparation of its selenization modified polysaccharide. The polysaccharide and selenized polysaccharide prepared by the present invention have certain anti-HepG-2 tumor activity. It lays a theoretical foundation for the structural modification of polysaccharides, the activity analysis of polysaccharides, and the development of functional health care products and drugs related to anti-tumor diseases.
本发明的目的是通过以下技术方案实现的:The purpose of this invention is to realize through the following technical solutions:
具有生物活性的紫花苜蓿根部多糖及其硒化改性多糖的制备,其制备过程包括:The preparation of biologically active alfalfa root polysaccharide and its selenization modified polysaccharide includes:
(1)取干燥的紫花苜蓿根,依次用石油醚,乙醇回流提取去除脂和小分子后,加入蒸馏水加热回流2~6次,过滤,合并滤液;去蛋白,去色素后得到紫花苜蓿粗多糖;将得到的粗多糖经过阴离子交换柱层析分离,依次用蒸馏水﹑0.1~0.5 mol/L的NaCl溶液进行洗脱,用凝胶纯化后得到2个新的紫花苜蓿根部多糖RAPS-1和RAPS-2;(1) Take the dried alfalfa root, extract with petroleum ether and ethanol in turn to remove lipids and small molecules, add distilled water and heat under reflux for 2 to 6 times, filter, and combine the filtrates; after deproteinization and depigmentation, alfalfa crude polysaccharide is obtained The obtained crude polysaccharide was separated by anion exchange column chromatography, eluted with distilled water and 0.1-0.5 mol/L NaCl solution in turn, and 2 new alfalfa root polysaccharides RAPS-1 and RAPS were obtained after gel purification. -2;
(2)将上述步骤(1)种得到的产量较大的多糖RAPS-2用硝酸-亚硒酸钠(NA-SS)法进行硒化修饰得到1个新的硒多糖Se-RAPS-2。(2) The high yield polysaccharide RAPS-2 obtained in the above step (1) is selenized modified by the nitric acid-sodium selenite (NA-SS) method to obtain a new selenopolysaccharide Se-RAPS-2.
所述的具有生物活性的紫花苜蓿根部多糖及其硒化改性多糖的制备,所述制得的2个新的紫花苜蓿根部多糖,其结构片段分别为:The preparation of the biologically active alfalfa root polysaccharide and its selenization modified polysaccharide, the structural fragments of the two new alfalfa root polysaccharides prepared are:
RAPS-1:→2)-α- L -Rhap-(1→,α- D -GalAp-(1→,→4)-β- D -Manp-(1→,→5)-α-L -Arap-(1→,→3)-β- D -Xylp-(1→和→6)-β- D -Glcp-(1→;RAPS-1:→2)-α-L-Rhap-(1→,α-D-GalAp-(1→,→4)-β-D-Manp-(1→,→5)-α-L- Arap-(1→,→3)-β-D-Xylp-(1→ and →6)-β-D-Glcp-(1→;
RAPS-2:→3)-α- L -Rhap-(1→,→2)-α- L -Rhap-(1→,→6)-α- D -Galp-(1→,α-D -GalAp-(1→,α- D -Glcp-(1→,→3)-β- D -Manp-(1→和→3)-β- D -Xylp(1→。RAPS-2: →3)-α-L-Rhap-(1→,→2)-α-L-Rhap-(1→,→6)-α-D-Galp-(1→,α-D- GalAp-(1→,α-D-Glcp-(1→,→3)-β-D-Manp-(1→ and →3)-β-D-Xylp(1→.
所述的具有生物活性的紫花苜蓿根部多糖及其硒化改性多糖的制备,制得的紫花苜蓿根部多糖和硒多糖均具有抗HepG-2肿瘤活性,在浓度为100 μM时,DAPS-1,DAPS-2和Se-DAPS-对HepG-2肿瘤的抑制作用分别为30.35%,17.81%和38.70%。The preparation of the biologically active alfalfa root polysaccharide and its selenization modified polysaccharide, the obtained alfalfa root polysaccharide and selenium polysaccharide both have anti-HepG-2 tumor activity, and when the concentration is 100 μM, DAPS-1 , DAPS-2 and Se-DAPS- inhibited HepG-2 tumors by 30.35%, 17.81% and 38.70%, respectively.
本发明提供的是紫花苜蓿根部多糖及其硒化改性多糖。上述多糖具有一定的抗HepG-2肿瘤活性。The invention provides alfalfa root polysaccharide and its selenization modified polysaccharide. The above polysaccharides have certain anti-HepG-2 tumor activity.
本发明是通过以下步骤得到的:The present invention is obtained through the following steps:
紫花苜蓿根部多糖的制备:Preparation of alfalfa root polysaccharide:
紫花苜蓿根用石油醚、乙醇回流处理,去除脂质和小分子化合物,再用蒸馏水回流冷凝提取2~6次,过滤,减压浓缩,合并浸膏。将中性蛋白酶与浸膏混合,40~60 oC培养1~3 h,80~100 oC灭活10~20 min,离心得到上清液。在上清液中加入由正丁醇和氯仿制备的Sevage试剂(1:2~1:4, v/v),搅拌一定时间后去除蛋白,离心,收集上清液,用Sevage试剂法去除蛋白2~5次。将上述得到的上清液浓缩,AB-8树脂柱脱色,用蒸馏水洗脱,减压浓缩,得到粗多糖。采用DEAE-52纤维素柱对粗多糖进行分离,用蒸馏水和不同浓度的NaCl溶液进行洗脱。苯酚-硫酸法测定其糖含量。采用Sephadex G-200柱对所得的馏分进行纯化,收集糖含量较多的2个组分,减压浓缩干燥得到2个新的多糖(DAPS-1,DAPS-2)。The alfalfa root is refluxed with petroleum ether and ethanol to remove lipids and small molecular compounds, then refluxed and extracted with distilled water for 2 to 6 times, filtered, concentrated under reduced pressure, and combined with the extract. Mix neutral protease with extract, incubate at 40-60 o C for 1-3 h, inactivate at 80-100 o C for 10-20 min, and centrifuge to obtain supernatant. Sevage reagent (1:2~1:4, v/v) prepared from n-butanol and chloroform was added to the supernatant, stirred for a certain period of time to remove the protein, centrifuged to collect the supernatant, and the
对上述得到的量大的DAPS-2进行硒化反应,在硝酸条件下,亚硒酸钠与多糖在60~80 oC下反应4~8 h,反应液经过透析,得到1个新的硒多糖(Se-DAPS-2)。The large amount of DAPS-2 obtained above was subjected to selenization reaction. Under the condition of nitric acid, sodium selenite and polysaccharide were reacted at 60-80 o C for 4-8 h, and the reaction solution was dialyzed to obtain a new selenium Polysaccharide (Se-DAPS-2).
上述得到的2个新的紫花苜蓿根部多糖,其分子量范围为10.0 KDa至16.0 KDa,主要是由鼠李糖,阿拉伯糖,木糖,葡萄糖醛酸,甘露糖,葡萄糖和半乳糖组成,其摩尔比的范围为(1.00~1.30):(1.50~3.20):(0~2.70):(3.50~5.50):(0~3.20):(2.70~5.10):(0~1.00)。1种硒化多糖的分子量范围为10.0 KDa至12.0 KDa,硒含量的范围为300~350μg/g。The two new alfalfa root polysaccharides obtained above have molecular weights ranging from 10.0 KDa to 16.0 KDa, and are mainly composed of rhamnose, arabinose, xylose, glucuronic acid, mannose, glucose and galactose. The range of the ratio is (1.00~1.30):(1.50~3.20):(0~2.70):(3.50~5.50):(0~3.20):(2.70~5.10):(0~1.00). The molecular weight of a selenized polysaccharide ranged from 10.0 KDa to 12.0 KDa, and the selenium content ranged from 300 to 350 μg/g.
本发明提供的2个新的紫花苜蓿根部多糖和1个硒多糖,采用细胞毒实验对DAPS-1、DAPS-2和Se-DAPS-2的抗HepG-2肿瘤活性进行了鉴定。Two new alfalfa root polysaccharides and one selenium polysaccharide provided by the present invention were used to identify the anti-HepG-2 tumor activity of DAPS-1, DAPS-2 and Se-DAPS-2 by cytotoxicity experiments.
抗HepG-2肿瘤活性表明在浓度为100 μM时,DAPS-1,DAPS-2和Se-DAPS-2对HepG-2肿瘤的抑制作用分别为30.35%,17.81%和38.70%。结果表明,Se-DAPS-2对HepG-2肿瘤细胞的抑制作用高于DAPS-1和DAPS-2。Anti-HepG-2 tumor activity showed that DAPS-1, DAPS-2 and Se-DAPS-2 inhibited HepG-2 tumor by 30.35%, 17.81% and 38.70%, respectively, at a concentration of 100 μM. The results showed that the inhibitory effect of Se-DAPS-2 on HepG-2 tumor cells was higher than that of DAPS-1 and DAPS-2.
综上所述,本发明制备的多糖化和硒化多糖具有一定的抗HepG-2肿瘤活性。为多糖的结构修饰,多糖的活性分析以及抗肿瘤方面疾病有关的功能性保健品和药物的开发奠定了理论基础。In conclusion, the polysaccharide and selenylated polysaccharides prepared by the present invention have certain anti-HepG-2 tumor activity. It lays a theoretical foundation for the structural modification of polysaccharides, the activity analysis of polysaccharides, and the development of functional health care products and drugs related to anti-tumor diseases.
附图说明Description of drawings
图1是RAPS-1的1H-NMR图谱;Fig. 1 is the 1 H-NMR spectrum of RAPS-1;
图2是RAPS-1的13C-NMR图谱;Fig. 2 is the 13 C-NMR spectrum of RAPS-1;
图3是RAPS-1的HSQC图谱;Fig. 3 is the HSQC pattern of RAPS-1;
图4是RAPS-1的HMBC图谱;Fig. 4 is the HMBC map of RAPS-1;
图5是RAPS-2的1H-NMR图谱;Fig. 5 is the 1 H-NMR spectrum of RAPS-2;
图6是RAPS-2的13C-NMR图谱;Fig. 6 is the 13 C-NMR spectrum of RAPS-2;
图7是RAPS-2的HSQC图谱;Fig. 7 is the HSQC pattern of RAPS-2;
图8是RAPS-2的HMBC图谱;Fig. 8 is the HMBC map of RAPS-2;
图9是Se-RAPS-2的1H-NMR图谱;Fig. 9 is the 1 H-NMR spectrum of Se-RAPS-2;
图10是Se-RAPS-2的13C-NMR图谱;Figure 10 is the 13 C-NMR spectrum of Se-RAPS-2;
图11是紫花苜蓿根部多糖的单糖组成谱图;Figure 11 is a monosaccharide composition spectrum of alfalfa root polysaccharide;
图12是紫花苜蓿根部多糖和硒化多糖(RAPS-1,RAPS-2,Se-RAPS-2)对HepG-2肿瘤细胞抑制作用。Figure 12 is the inhibitory effect of alfalfa root polysaccharides and selenized polysaccharides (RAPS-1, RAPS-2, Se-RAPS-2) on HepG-2 tumor cells.
具体实施方式Detailed ways
下面通过具体实施例对本发明进行说明,但本发明并不局限于此。下述实施例中所述实验方法,如无特殊说明,均为常规方法;所述试剂和生物材料,如无特殊说明,均可从商业途径获得。The present invention will be described below through specific embodiments, but the present invention is not limited thereto. The experimental methods described in the following examples are conventional methods unless otherwise specified; the reagents and biological materials can be obtained from commercial sources unless otherwise specified.
实施例1 紫花苜蓿根部多糖的提取Example 1 Extraction of polysaccharides from alfalfa roots
紫花苜蓿根(2.0 kg)依次用石油醚,乙醇回流处理,过滤,取滤渣用蒸馏水回流冷凝提取2~6次,过滤,减压浓缩,合并浸膏。将中性蛋白酶与浸膏混合,40~60 oC培养1~3 h,在80~100 oC条件下灭活10~20 min,离心得到上清液。在上清液中加入由正丁醇和氯仿制备的Sevage试剂(1:2~1:4, v/v),强力搅拌去除蛋白,离心,收集上清液。用Sevage法去除蛋白2~5次。将上述得到的上清液浓缩,AB-8树脂柱脱色,得到粗多糖。采用DEAE-52纤维素柱对粗多糖进行分离,用蒸馏水和不同浓度的NaCl溶液进行洗脱。苯酚-硫酸法测定其糖含量。采用Sephadex G-200柱对所得的馏分进行纯化收集糖含量较多的2个组分(RAPS-1,RAPS-2),减压浓缩干燥得到多糖(RAPS-1,RAPS-2)。核磁谱图(600 MHz, D2O)如图1,由1H-NMR可知,RAPS-1:由1H-NMR可知,在δ1.23和1.38 ppm 处的信号代表了DAPS-1中鼠李糖甲基的存在。信号在δ2.06, 2.14, 2.22和2.29处是由于乙酰基的质子引起的。δ3.39−4.25ppm的信号范围代表了糖苷环上的H-2到 H-5(或 H-6)。由13C-NMR可知,δ16.5 ppm代表了鼠李糖甲基的信号。δ60.7-75.8 ppm的信号范围代表了DAPS-2中的非异头碳原子,信号范围在δ96.0-107.1 ppm处是由于糖残基中C-2到 C-6的共振引起的。δ174.1 ppm处的信号说明DAPS-1中存在糖醛酸。结合13C-NMR和HSQC可知,δ5.23/100.8 ppm,5.13/99.6 ppm,4.99/100.4 ppm,5.06/107.1 ppm,4.60/102.6 ppm和4.54/104.2 ppm分别是→2)-α-L-Rhap-(1→,α-D-GalAp-(1→,→4)-β-D-Manp-(1→,→5)-α-L-Arap-(1→,→3)-β-D-Xylp-(1→和→6)-β-D-Glcp-(1→的端基氢与端基碳的相关信号。由HMBC可知,δ4.60/78.7 ppm是→3)-β-D-Xylp-(1→的H-1和C-3的相关信号,δ5.13/81.3 ppm是α-D-GalAp-(1→的H-1与→2)-α-L-Arap-(1→的C-2的相关信号,δ4.54/69.1 ppm 是→6)-β-D-Glcp-(1→的H-1/C-6的相关信号。Alfalfa root (2.0 kg) was treated with petroleum ether and ethanol under reflux in turn, filtered, the filter residue was collected and extracted with distilled water under reflux for 2 to 6 times, filtered, concentrated under reduced pressure, and the extract was combined. Mix neutral protease and extract, incubate at 40-60 o C for 1-3 h, inactivate at 80-100 o C for 10-20 min, and centrifuge to obtain supernatant. Sevage reagent (1:2-1:4, v/v) prepared from n-butanol and chloroform was added to the supernatant, and the protein was removed by vigorous stirring, and the supernatant was collected by centrifugation. Use the Sevage method to remove the
RAPS-2:由1H-NMR可知,在δ 1.23, 1.35 和 1.46 ppm 处的信号代表了DAPS-2中鼠李糖甲基的存在。信号在δ1.90 和 2.07处是由于乙酰基的质子引起的。δ3.33−4.26 ppm的信号范围代表了糖苷环上的H-2 到 H-5 (或 H-6)。在δ4.41,4.54, 4.55,4.57处的信号表示了β端基质子的存在;δ5.08, 5.27, 5.28, 5.77的信号表示了α端基质子的存在。由13C-NMR可知,,δ16.5和16.7代表了鼠李糖甲基的信号。δ65.8-83.4 ppm的信号范围代表了DAPS-2中的非异头碳原子,信号范围在δ92.1-106.8 ppm处是由于糖残基中C-2 到 C-6的共振引起的。δ175.0和175.3处的信号说明DAPS-2中存在糖醛酸。结合13C-NMR和HSQC可知,δ5.08/103.6 ppm, 5.28/101.6 ppm, 4.95/97.6 ppm, 5.18/101.0 ppm, 4.98/98.7 ppm,4.64/101.6 ppm 和 4.61/103.3 ppm分别是→3)-α-L-Rhap-(1→, →2)-α-L-Rhap-(1→, →6)-α-D-Galp-(1→, α-D-GalAp-(1→, α-D-Glcp-(1→, →3)-β-D-Manp-(1→和→3)-β-D-Xylp(1→的端基氢与端基碳的相关信号。由HMBC可知,δ5.08/78.7 ppm是→3)-α-L-Rhap-(1→的H-1和C-3的相关信号,δ4.95/65.9 ppm是→6)-α-D-Galp-(1→的H-1/C-6的相关信号,δ5.18/ 70.1是α-D-GalAp-(1→的H-1与→6)-α-D-Galp-(1→的C-2的相关信号。δ4.98/ 81.1是α-D-Glcp-(1→的H-1与→3)-β-D-Manp-(1→的C-4的相关信号δ4.64/69.5ppm和δ4.61/81.1 ppm分别代表了→3)-β-D-Manp-(1→和→3)-β-D-Xylp(1→的H-1/C-3的相关信号。RAPS-2: The signals at δ 1.23, 1.35 and 1.46 ppm represent the presence of rhamnose methyl groups in DAPS-2 from 1 H-NMR. The signals at δ 1.90 and 2.07 are due to protons of the acetyl group. The signal range of δ 3.33−4.26 ppm represents H-2 to H-5 (or H-6) on the glycosidic ring. Signals at δ 4.41, 4.54, 4.55, 4.57 indicate the presence of β-terminal protons; signals at δ 5.08, 5.27, 5.28, 5.77 indicate the presence of α-terminal protons. From 13 C-NMR, δ 16.5 and 16.7 represent the signal of rhamnose methyl group. The signal range of δ 65.8-83.4 ppm represents the non-anomeric carbon atoms in DAPS-2, and the signal range of δ 92.1-106.8 ppm is due to the resonance of C-2 to C-6 in sugar residues. Signals at delta 175.0 and 175.3 indicate the presence of uronic acid in DAPS-2. Combining 13 C-NMR and HSQC, δ 5.08/103.6 ppm, 5.28/101.6 ppm, 4.95/97.6 ppm, 5.18/101.0 ppm, 4.98/98.7 ppm, 4.64/101.6 ppm and 4.61/103.3 ppm are →3)- α-L-Rhap-(1→, →2)-α-L-Rhap-(1→, →6)-α-D-Galp-(1→, α-D-GalAp-(1→, α- Correlation signals of terminal hydrogen and terminal carbon of D-Glcp-(1→, →3)-β-D-Manp-(1→ and →3)-β-D-Xylp(1→. From HMBC, we can see that, δ 5.08/78.7 ppm is →3)-α-L-Rhap-(1→ Correlation signals of H-1 and C-3, δ 4.95/65.9 ppm is →6)-α-D-Galp-(1→ The correlation signal of H-1/C-6, δ 5.18/70.1 is the correlation of α-D-GalAp-(1→H-1 with →6)-α-D-Galp-(1→C-2 Signal.δ 4.98/81.1 is the correlation signal of α-D-Glcp-(1→H-1 and →3)-β-D-Manp-(1→C-4 of C-4 δ 4.64/69.5ppm and δ 4.61/ 81.1 ppm represent the H-1/C-3 correlation signals of →3)-β-D-Manp-(1→ and →3)-β-D-Xylp(1→, respectively.
实施例2 硒化多糖的合成Example 2 Synthesis of Selenized Polysaccharide
取亚硒酸钠与RAPS-2以1:0.8~1:1.5的比例加入圆底烧瓶中,加稀HNO3溶液,70~90oC下反应8~12 h反应完成后,冷却至室温,用NaOH溶液调节溶液pH至6~8,用透析膜透析出亚硒酸钠等小分子化合物后,停止透析,冻干,得硒化多糖(Se-RAPS-2)。Take sodium selenite and RAPS-2 in a ratio of 1:0.8~1:1.5 into a round-bottomed flask, add dilute HNO3 solution, react at 70~90 o C for 8~12 h after the reaction is completed, cool to room temperature, The pH of the solution was adjusted to 6-8 with NaOH solution, and small molecular compounds such as sodium selenite were dialyzed with a dialysis membrane, then the dialysis was stopped, and lyophilized to obtain selenized polysaccharide (Se-RAPS-2).
Se-RAPS-2的1H-NMR和RAPS-2相似,在δ 1.24和1.30 ppm 处的信号代表了Se-DAPS-2中鼠李糖甲基的存在。信号在δ 2.11 和 2.20 ppm处是由于乙酰基的质子引起的。δ3.25−4.13 ppm的信号范围代表了糖苷环上的H-2 到 H-5 (或 H-6)。,在Se-DAPS-2的13C-NMR中,在δ62.5 ppm处的新峰归属为O-6取代的碳原子共振,代表O-6的反应,说明RAPS-2的C-6被硒原子取代。The 1 H-NMR of Se-RAPS-2 is similar to RAPS-2, the signals at δ 1.24 and 1.30 ppm represent the presence of rhamnose methyl groups in Se-DAPS-2. The signals at δ 2.11 and 2.20 ppm are due to protons of the acetyl group. The signal range of δ3.25−4.13 ppm represents H-2 to H-5 (or H-6) on the glycosidic ring. , in the 13 C-NMR of Se-DAPS-2, a new peak at δ 62.5 ppm is assigned to the O-6 substituted carbon atom resonance, representing the reaction of O-6, indicating that the C-6 of RAPS-2 is replaced by selenium Atomic substitution.
实施例3 紫花苜蓿根部多糖单糖组成的测定Example 3 Determination of polysaccharide and monosaccharide composition of alfalfa roots
取RAPS-1和RAPS-2样品适量,用一定浓度的三氟乙酸溶解,在80~120 oC油浴反应4~10 h。反应完成后用无水甲醇用旋转蒸发仪,重复数次带走残留的三氟乙酸。最后用少量乙腈:水= 70~90:10~30溶解样品,过0.22 μm有机滤头。Take appropriate amount of RAPS-1 and RAPS-2 samples, dissolve them with a certain concentration of trifluoroacetic acid, and react in an oil bath of 80-120 o C for 4-10 h. After the completion of the reaction, use anhydrous methanol with a rotary evaporator to remove the residual trifluoroacetic acid several times. Finally, dissolve the sample with a small amount of acetonitrile: water = 70~90:10~30, and pass through a 0.22 μm organic filter.
色谱条件:LC-20AR高效液相色谱仪;Chromatographic conditions: LC-20AR high performance liquid chromatograph;
色谱柱:HP-Amino (4.6×250 mm,5 μm);Chromatographic column: HP-Amino (4.6×250 mm, 5 μm);
检测器:RID-20A示差折光检测器;Detector: RID-20A refractive index detector;
流动相:A为乙腈,B为水,A:B= 70~80:20~30;Mobile phase: A is acetonitrile, B is water, A:B=70~80:20~30;
柱温:20~40 oC;Column temperature: 20~40 o C;
流速:0.2~0.8 mL/min;Flow rate: 0.2~0.8 mL/min;
进样量:30~60 μL;Injection volume: 30~60 μL;
用600 μL乙腈:水= 70~90:10~30溶解样品,过0.22 μm有机滤头。Dissolve the sample with 600 μL acetonitrile: water = 70~90:10~30, and pass through a 0.22 μm organic filter.
色谱图见图11,由图可知RAPS-1的是由鼠李糖(Rha),阿拉伯糖(Ara),木糖(xyl),葡萄糖醛酸(GlcA)和葡萄糖(Glc)组成,摩尔比为:1.00:3.19:2.67:5.44:5.10。,DAPS-2由鼠李糖(Rha),阿拉伯糖(Ara),葡萄糖醛酸(GlcA),甘露糖(Man),葡萄糖(Glc)和半乳糖(Gla)组成,摩尔比为:1.21:1.49:3.49:3.11:2.73:1.00。The chromatogram is shown in Figure 11. It can be seen from the figure that RAPS-1 is composed of rhamnose (Rha), arabinose (Ara), xylose (xyl), glucuronic acid (GlcA) and glucose (Glc), and the molar ratio is : 1.00:3.19:2.67:5.44:5.10. , DAPS-2 is composed of rhamnose (Rha), arabinose (Ara), glucuronic acid (GlcA), mannose (Man), glucose (Glc) and galactose (Gla), the molar ratio is: 1.21:1.49 :3.49:3.11:2.73:1.00.
实施例4 紫花苜蓿根部多糖和硒化多糖分子量的测定Example 4 Determination of molecular weight of alfalfa root polysaccharides and selenized polysaccharides
称取一定量的分子量为 T4(4000 Da)、T10(10000 Da)、T20(20000 Da)、T40(40000Da)、T200(200000 Da)、T500(500000 Da)的葡聚糖标准品和RAPS-1,RAPS-2和Se-RAPS-2,加0.5~2 mL娃哈哈纯净水溶解,充分混匀,得标准品溶液,过0.22 μm滤膜备用。Weigh out a certain amount of dextran standards and RAPS- 1. Dissolve RAPS-2 and Se-RAPS-2 in 0.5-2 mL of Wahaha pure water, mix thoroughly to obtain a standard solution, which is passed through a 0.22 μm filter membrane for use.
色谱条件:LC-20AR 高效液相色谱仪;Chromatographic conditions: LC-20AR high performance liquid chromatograph;
检测器:RID-20A示差折光检测器;Detector: RID-20A refractive index detector;
色谱柱:A TSK gel G 5000 PW column (I.D.=7.5mm, L=300mm);Chromatographic column: A TSK gel G 5000 PW column (I.D.=7.5mm, L=300mm);
流动相:0.02~0.05 mol/L KH2PO4;Mobile phase: 0.02~0.05 mol/L KH 2 PO 4 ;
柱温:20~40 oC;Column temperature: 20~40 o C;
流速:0.2~0.8 mL/min;Flow rate: 0.2~0.8 mL/min;
进样量:30~60 μL;Injection volume: 30~60 μL;
根据标准葡聚糖的分子量对数和出峰时间得出标准曲线,由多糖及硒化多糖的出峰时间可知,RAPS-1,RAPS-2和Se-RAPS-2的分子量分别为10.0 KDa, 15.8 KDa 和11.0 KDa。According to the molecular weight logarithm and peak time of standard dextran, the standard curve was obtained. According to the peak time of polysaccharide and selenized polysaccharide, the molecular weights of RAPS-1, RAPS-2 and Se-RAPS-2 were 10.0 KDa, respectively. 15.8 KDa and 11.0 KDa.
实施例5 硒化多糖硒含量的测定Example 5 Determination of selenium content of selenized polysaccharides
称取一定量样品于三角瓶中,加6~12 mL硝酸和2~6 mL高氯酸,常温下避光放置12~20 h以上,然后在加热套上160~220 oC加热消化,待溶液呈无色或微黄色时,再加入6~12mL盐酸(0.5~1.0 mol/mL),继续加热至溶液为1 mL左右,冷却,同时做空白试验。将浓盐酸用蒸馏水稀释到6 mol/L,将消化后的溶液加到比色管中,然后加入2~8 mol/L 的盐酸,放置在70~100 oC的恒温槽中加热1~3 h后取出冷却,用蒸馏水稀释,即可用原子荧光光谱仪检测。结果表明Se-RAPS-2的硒含量是320 μg/g。Weigh a certain amount of sample into a conical flask, add 6-12 mL of nitric acid and 2-6 mL of perchloric acid, and place it in the dark for more than 12-20 h at room temperature, then heat and digest at 160-220 o C on a heating mantle, wait for When the solution is colorless or slightly yellow, add 6-12 mL of hydrochloric acid (0.5-1.0 mol/mL), continue to heat until the solution is about 1 mL, cool, and do a blank test at the same time. Dilute concentrated hydrochloric acid with distilled water to 6 mol/L, add the digested solution to the colorimetric tube, then add 2-8 mol/L hydrochloric acid, and place it in a constant temperature bath at 70-100 o C for 1-3 After h, it was taken out and cooled, diluted with distilled water, and then detected by atomic fluorescence spectrometer. The results showed that the selenium content of Se-RAPS-2 was 320 μg/g.
实施例6 体外抗肿瘤实验Example 6 In vitro anti-tumor experiment
取对数生长期的人肝癌细胞(HepG2),于RPMI-1640(含10%胎牛血清)培养基中,以每孔5000个/孔,每孔100 μL的细胞悬液接种于96孔板中,置5% CO2,37 ℃培养箱中培养过夜12h。之后将上清液(培养基)吸取弃去。加入100 μL含多糖样品的培养基,多糖浓度分别为0、6.25、12.5、25、50、100 μM,每个浓度设3个平行,继续培养48 h后,加入10 μL的CCK-8试剂,继续培养2 h,用酶标仪在450 nm下测各孔吸光度值。同时设置空白对照组为无肝癌细胞(HepG2)和多糖样品,只有培养基和CCK-8溶液。按以下公式计算癌细胞抑制率:Human hepatoma cells (HepG2) in the logarithmic growth phase were taken and placed in RPMI-1640 (containing 10% fetal bovine serum) medium, 5000 cells per well, 100 μL of cell suspension per well were inoculated in 96-well plates in 5% CO 2 , incubator at 37 °C overnight for 12 h. The supernatant (medium) was then aspirated and discarded. Add 100 μL of culture medium containing polysaccharide samples, the polysaccharide concentrations are 0, 6.25, 12.5, 25, 50, and 100 μM, and each concentration is set to 3 parallels. After culturing for 48 hours, 10 μL of CCK-8 reagent is added. Continue to cultivate for 2 h, and measure the absorbance value of each well at 450 nm with a microplate reader. At the same time, the blank control group was set as no hepatoma cells (HepG2) and polysaccharide samples, only medium and CCK-8 solution. Calculate the cancer cell inhibition rate according to the following formula:
癌细胞抑制率(%)=1-[(As-A0)/(A1-A0)]×100%;Cancer cell inhibition rate (%)=1-[(A s -A 0 )/(A 1 -A 0 )]×100%;
式中:As为实验组的OD值;A1为多糖溶度为0 μM实验组的OD值;A0为空白对照组OD值。In the formula: A s is the OD value of the experimental group; A 1 is the OD value of the experimental group whose polysaccharide solubility is 0 μM; A 0 is the OD value of the blank control group.
结果表明,DAPS-1和Se-DAPS-2有一定的HepG-2肿瘤细胞抑制作用,并呈浓度依赖性。Se-DAPS-2对HepG-2肿瘤细胞的抑制作用高于DAPS-1和DAPS-2。The results showed that DAPS-1 and Se-DAPS-2 had a certain inhibitory effect on HepG-2 tumor cells in a concentration-dependent manner. The inhibitory effect of Se-DAPS-2 on HepG-2 tumor cells was higher than that of DAPS-1 and DAPS-2.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910971326.1A CN110862463A (en) | 2019-10-14 | 2019-10-14 | Preparation of alfalfa root polysaccharide with bioactivity and selenizing modified polysaccharide thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910971326.1A CN110862463A (en) | 2019-10-14 | 2019-10-14 | Preparation of alfalfa root polysaccharide with bioactivity and selenizing modified polysaccharide thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110862463A true CN110862463A (en) | 2020-03-06 |
Family
ID=69652159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910971326.1A Pending CN110862463A (en) | 2019-10-14 | 2019-10-14 | Preparation of alfalfa root polysaccharide with bioactivity and selenizing modified polysaccharide thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110862463A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112724270A (en) * | 2020-12-30 | 2021-04-30 | 盐城工学院 | Low-molecular-weight alfalfa polysaccharide, preparation method thereof and application of low-molecular-weight alfalfa polysaccharide in regulating intestinal flora |
| CN114853918A (en) * | 2022-04-26 | 2022-08-05 | 沈阳化工大学 | Preparation method of alfalfa root polysaccharide with antioxidant and lipid-lowering activities |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS227759B1 (en) * | 1983-01-24 | 1984-05-14 | Peter Prom Chem Capek | Process for preparing biologically active polysaccharides from the roots of Ibisa medical |
| US5417229A (en) * | 1993-07-20 | 1995-05-23 | Summers; John K. | Organoleptic bite composition for human consumption |
| WO1999057299A1 (en) * | 1998-05-05 | 1999-11-11 | Albright & Wilson (Australia) Limited | Cultured plant cell gums of aizoaceae: food, pharmaceutical, cosmetic and industrial applications of cultured plant cell gums of aizoaceae and other plant families |
| CN102212144A (en) * | 2011-04-15 | 2011-10-12 | 沈阳农业大学 | Method for preparing pure polysaccharose from alfalfa hay |
| CN103910807A (en) * | 2014-03-24 | 2014-07-09 | 四川宝紫苜科技有限公司 | Separation method of alfalfa extract active components in alfalfa |
| CN110105460A (en) * | 2019-05-24 | 2019-08-09 | 武汉轻工大学 | Selenizing carboxymethylpachymaran and preparation method and application |
-
2019
- 2019-10-14 CN CN201910971326.1A patent/CN110862463A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS227759B1 (en) * | 1983-01-24 | 1984-05-14 | Peter Prom Chem Capek | Process for preparing biologically active polysaccharides from the roots of Ibisa medical |
| US5417229A (en) * | 1993-07-20 | 1995-05-23 | Summers; John K. | Organoleptic bite composition for human consumption |
| WO1999057299A1 (en) * | 1998-05-05 | 1999-11-11 | Albright & Wilson (Australia) Limited | Cultured plant cell gums of aizoaceae: food, pharmaceutical, cosmetic and industrial applications of cultured plant cell gums of aizoaceae and other plant families |
| CN102212144A (en) * | 2011-04-15 | 2011-10-12 | 沈阳农业大学 | Method for preparing pure polysaccharose from alfalfa hay |
| CN103910807A (en) * | 2014-03-24 | 2014-07-09 | 四川宝紫苜科技有限公司 | Separation method of alfalfa extract active components in alfalfa |
| CN110105460A (en) * | 2019-05-24 | 2019-08-09 | 武汉轻工大学 | Selenizing carboxymethylpachymaran and preparation method and application |
Non-Patent Citations (5)
| Title |
|---|
| YUHUAI XIE ET AL.: "Immunomodulatory, antioxidant and intestinal morphology-regulating activities of alfalfa polysaccharides in mice", 《INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES》 * |
| 刘立新等: "紫花苜蓿多糖的体外抗肿瘤活性研究", 《食品研究与开发》 * |
| 张东杰等: "苜蓿多糖抗肿瘤活性初探", 《中国食品学报》 * |
| 王洪荣主编: "《粗饲料资源高效利用》", 31 January 2012 * |
| 郑文杰编著: "《植物有机硒的化学及其医学应用》", 31 July 2001 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112724270A (en) * | 2020-12-30 | 2021-04-30 | 盐城工学院 | Low-molecular-weight alfalfa polysaccharide, preparation method thereof and application of low-molecular-weight alfalfa polysaccharide in regulating intestinal flora |
| CN114853918A (en) * | 2022-04-26 | 2022-08-05 | 沈阳化工大学 | Preparation method of alfalfa root polysaccharide with antioxidant and lipid-lowering activities |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Structural features and anti-gastric cancer activity of polysaccharides from stem, root, leaf and flower of cultivated Dendrobium huoshanense | |
| Meng et al. | Structural characterization and immunomodulating activities of polysaccharides from a newly collected wild Morchella sextelata | |
| CN112920287B (en) | Amomum villosum polysaccharide with immunoregulation effect and preparation method and application thereof | |
| CN103910809B (en) | The separation purification method of Chinese yam polysaccharide | |
| Du et al. | Delayed growth of glioma by a polysaccharide from Aster tataricus involve upregulation of Bax/Bcl-2 ratio, activation of caspase-3/8/9, and downregulation of the Akt | |
| Yao et al. | Two complement fixing pectic polysaccharides from pedicel of Lycium barbarum L. promote cellular antioxidant defense | |
| CN111019008A (en) | Anti-inflammatory activity phellinus igniarius polysaccharide SHP and preparation method thereof | |
| CN115651089A (en) | A Gastrodia elata polysaccharide with antioxidant activity | |
| CN115558035B (en) | Gastrodia polysaccharide with immunoregulatory activity | |
| CN107698695A (en) | Homogeneous polysaccharide with immunomodulatory action and preparation method thereof | |
| CN110862463A (en) | Preparation of alfalfa root polysaccharide with bioactivity and selenizing modified polysaccharide thereof | |
| Zhang et al. | Structural analysis, anti-inflammatory activity of the main water-soluble acidic polysaccharides (AGBP-A3) from Panax quinquefolius L berry | |
| CN108191931A (en) | Three kinds of noval chemical compounds and its health care and medical usage in root of Paeonia sinjiangensis | |
| CN112759661B (en) | Cherokee rose fruit polysaccharide preparation method, identification method and application | |
| JP2008212137A (en) | A novel method for producing ginsenoside from carrot by liquid culture of perinus linteus mycelium using biotransformation method | |
| Zhan et al. | Optimization of the polysaccharide extraction process from Rosa roxburghii Tratt using Box-Behnken response surface methodology and monosaccharide composition analysis | |
| CN114853918B (en) | Preparation method of alfalfa root polysaccharide with antioxidant and lipid-lowering activities | |
| Zhou et al. | Preparation, analysis and activity of Malus prunifolia polysaccharide | |
| CN114409818B (en) | Preparation method and application of physalis pubescens polysaccharide selenide | |
| CN102772501A (en) | Rheum emodi Wall. extract and its preparing method | |
| Xu et al. | Identification of polysaccharides from Dipsacus asperoides and their effects on osteoblast proliferation and differentiation in a high-glucose environment | |
| CN113004299B (en) | Xanthone compound in mangosteen bark for reducing postprandial blood sugar, and extraction method and application thereof | |
| CN108530547B (en) | A kind of arabinogalactan KMCP, its preparation method and application in preparing immunomodulator | |
| Yu et al. | Extraction, characterization, and biological activities of a novel polysaccharide extract from Fructus caryophylli | |
| CN112794923A (en) | Ligusticum chuanxiong polysaccharide and its preparation method, identification method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200306 |
|
| WD01 | Invention patent application deemed withdrawn after publication |